K-pop Comebacks, Charts and Agency Power — 2026-10-08
October 2026 sees a fierce K-pop comeback race with IVE, ILLIT, and RIIZE releasing on the same day, while BTS surpasses $500 million in tour ticket sales. HYBE stock rebounded by 6% amid Q3 profit turnaround forecasts, driven by new group success and strong performance from its US-based acts.
K-pop Comebacks, Charts and Agency Power — 2026-10-08
Top developments
BTS Becomes First Pop Group to Surpass $500 Million in Tour Ticket Sales
On October 1, 2026, The Korea Times reported that BTS has become the first pop group in history to surpass $500 million in cumulative ticket sales for a single tour. This milestone was achieved during their ongoing "Arirang" world tour, which also returned to the No. 1 spot on Billboard's Top Tours chart. This record underscores the continued global dominance of HYBE’s flagship group and sets a new benchmark for live performance revenue in the industry.
October Comeback War: IVE, ILLIT, and RIIZE Release on Same Day
The Korea Times highlighted on October 6 that the post-Chuseok period has triggered a crowded release schedule, with major groups like IVE, ILLIT, and RIIZE colliding on October 26. This strategic clustering is designed to maximize chart impact and media coverage during the autumn season. The intense competition among SM Entertainment (IVE) and HYBE labels (ILLIT, RIIZE) reflects the agencies' reliance on synchronized releases to boost first-week sales and streaming numbers.
HYBE Stock Rises 6% on Q3 Profit Turnaround Forecast
On October 7, HYBE shares jumped nearly 6% in midday trading following analyst forecasts of a return to profitability in the third quarter. Infostock Daily reported that Hana Securities projected HYBE’s Q3 revenue at 1.47 trillion won (+101% YoY) and operating profit at 165.7 billion won, marking a significant turnaround. The positive sentiment is driven by the commercial success of new groups and the debut of a US-based male group, signaling a successful diversification of HYBE’s portfolio beyond BTS.
CLOSE YOUR EYES Breaks Career High with 710,000 First-Week Sales
On October 8, News Culture reported that the boy group CLOSE YOUR EYES achieved a career-high first-week album sales figure of over 710,000 copies. This milestone demonstrates the "staircase growth" model many newer groups are adopting, where each comeback significantly outperforms the last. Such figures are critical for agency valuations, as consistent sales growth reduces reliance on a single top-tier IP and stabilizes revenue streams.
Local view
The Korean business press is focusing heavily on the divergence in entertainment stock performance. While Chosun Ilbo noted earlier in September that HYBE and JYP stocks had fallen significantly over the past six months due to artist dependency issues, the recent rebound in HYBE’s stock suggests investors are reassessing the value of new IP pipelines. Infostock Daily emphasizes that the market is now pricing in the success of HYBE's new groups and US ventures as a key driver for future profitability, moving away from pure BTS-centric valuations.
Context & numbers
- Tour Revenue: BTS's "Arirang" tour has grossed over $500 million in ticket sales, a first for any pop group.
- HYBE Q3 Forecast: Projected revenue of 1.47 trillion won and operating profit of 165.7 billion won for Q3 2026.
- Sales Milestone: CLOSE YOUR EYES sold 710,000+ copies in their first week, setting a new personal record.
- Release Schedule: Key October releases include LISA (Oct 23), NMIXX (Oct 19), and the triple-collision of IVE, ILLIT, and RIIZE (Oct 26).
On the radar
- LISA's Solo Release: BLACKPINK member LISA is scheduled to release new music on October 23, expected to drive significant streaming numbers for YG Entertainment.
- Q4 Calendar Expansion: Forbes updated its Q4 2026 calendar, confirming additional releases from JENNIE, TXT, and various new debuts through December, indicating a sustained high-volume release strategy across major agencies.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
